Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IL-2 After Docetaxel in Hormone Refractory Metastatic Prostate Cancer
NCT00283829Phase 2Completed
- Sponsor
- University of Washington
- Start
- Sep 2002
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of aldesleukin in prostate cancer (PCa), sponsored by University of Washington. Started Sep 2002; status: completed.
02
Drugs
aldesleukin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00283829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00283829.